Navigation Links
GEN reports on biotech acquisition deals in 2010 that topped $1 billion
Date:1/10/2011

New Rochelle, NY, January 10, 2011The mega-mergers of 2009 did not continue into 2010. While the three biggest acquisitions in 2009 each had a price tag of more than $40 billion, only last year's top purchase got above that mark, according to an evaluation of reported deals conducted by Genetic Engineering & Biotechnology News (GEN) (http://www.genengnews.com/). The only other mega takeover for the year, sanofi-aventis' move to buy Genzyme, is still being worked out.

A look at 2010's buyouts that crossed the $1billion mark (http://www.genengnews.com/gen-news-highlights/acquisition-deals-in-2010-that-topped-1b/81244443/) reveals interesting similarities with major acquisitions from past years. Prior finalists make a repeat appearance, and most organizations that have reported consolidation say that the mergers have been positive.

"I think the uncertainty surrounding the sanofi-aventis/Genzyme story put a break on the number of large mergers and acquisitions that might actually have taken place," says John Sterling, Editor in Chief of GEN. "Once that deal gets done, other big M&As are likely to follow."

Novartis' $41 billion purchase of Alcon, which has a significant portfolio of eye disease therapies, topped the list of acquisitions last year. Sanofi-aventis' bid for Genzyme of $18.5 billion, which still has to clear, grabbed the number two spot. Merck's foray into life science tools and services with its $5.2 billion acquisition of Millipore was next, followed by Teva paying 3.625 billion for ratiopharm to up its generic drug dominance.

Fifth place went to Astellas Pharma for picking up OSI Pharmaceuticals for $4 billion. Pfizer, 2009's top bidder, made the number six spot with its takeover of King Pharmaceuticals for $3.6 billion. Other acquisition deals that crossed the
'/>"/>

Contact: John Sterling
jsterling@genengnews.com
914-740-2196
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Page: 1 2

Related biology news :

1. LSUHSC reports first successful salivary stone removal with robotics
2. Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
3. Aware, Inc. Reports Third Quarter 2010 Financial Results
4. Smithsonian reports regional sea temperature rise and coral bleaching event in Western Caribbean
5. Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer
6. Terumo Medical Corp. reports first US implant in landmark study enrolling in US and Japan
7. GEN reports on the greening of the life sciences
8. Aware, Inc. Reports Second Quarter 2010 Financial Results
9. GEN reports on rediscovered technology to bolster proteomics research
10. BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results
11. International Drug & Explosives Detection Company IDenta Corp Reports on BTK- Bullet Hole Testing Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... 62/198989 for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD AND ... advance crypto-currencies such as Bitcoin into the consumer market ... to manage all payments.  The technology ...
(Date:7/30/2015)... , July 30, 2015 Cellecta, Inc., ... gene function analysis and biomarker discovery, announced the ... Knockout Library targeting all human protein coding genes. ... "knock out" a gene,s function. Cellecta,s new Human ... throughput screening tool so that researchers can investigate ...
(Date:7/27/2015)... , July 27, 2015   Zynx Health ... experience-based clinical improvement solutions, today announced that its ... now available on Android smartphones and tablets. With ... post-care organizations can use ZynxCarebook to securely exchange ... condition, streamline care transitions to other care settings, ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3
... Knut Stamnes, Professor and Department Director of Physics ... has been awarded a NASA grant for work ... satellite. His proposal to "use and further develop ... coupled atmosphere-surface systems" is funded as part of ...
... Senior Design team at Stevens Institute of Technology is ... arise during thoracic surgeries. Five undergraduate Biomedical Engineering students ... of existing catheter design and introduces a potentially profitable ... the efforts of the Stevens Innovative Fluid Extraction System ...
... revealing how age-old irrigation techniques may have boosted the ... an estimated 200 million people today. ... kingdom that was located in present-day Sudan, provides details ... disease across populations in ancient times, and how human ...
Cached Biology News:Dr. Knut Stamnes at Stevens receives NASA grant for environmental monitoring 2Dr. Knut Stamnes at Stevens receives NASA grant for environmental monitoring 3Stevens thoracic catheter senior design team takes 1st place at regional ISPE competition 2Stevens thoracic catheter senior design team takes 1st place at regional ISPE competition 3Mummies tell history of a 'modern' plague 2Mummies tell history of a 'modern' plague 3
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report on the ... of the global Propanol market with a focus on the Chinese situation. Major companies ... Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... of a field clinical study of its canine osteoarthritis stem cell product, currently ... Therapeutics (Kansas City, KS) and will be marketed in the US by Aratana. ...
(Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... Aug. 26 Bio-Reaction Industries is,pleased to announce ... executive,David Skiven as the newest member on their ... environmentally responsible innovations that Mr.,Skiven oversaw during his ... Group at GM, it,s logical that he would ...
... for Biopharmaceutical, Cell,Culture, Life Science Research and Diagnostics Industry Adds ... Productivity, ... Safety and Time to Market, FORT ... global supplier of animal free,products that enhance productivity, safety and ...
... NEEDHAM, Massachusetts, August 26 /PRNewswire-FirstCall/,-- Oridion Systems ... agreement with,Spacelabs Healthcare, a leading global medical ... now employs Oridion Microstream(R),capnography technology in its ... Spacelabs Healthcare, recognizing the importance of ...
Cached Biology Technology:GM Exec Joins Bio-Reaction Industries' Board of Directors 2InVitria Expands Sales Team 2InVitria Expands Sales Team 3Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare 2Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare 3Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare 4